Skip to main content

Table 2 Patient outcomes

From: Mortality and patient disposition after ICU tracheostomy for secretion management vs. prolonged ventilation: a retrospective cohort study

Outcome

All

(N = 247)

Secretion Management

(N = 133)

Prolonged Ventilation

(N = 114)

P value

Primary Outcome

    

Hospital mortality

86 (35%)

43 (32%)

43 (38%)

0.37

Secondary Outcome

    

ICU mortality

28-day mortality

1-year mortality*

47 (19%)

34 (14%)

106 (51%)

N = 207

13 (10%)

15 (11%)

51 (48%)

N = 106

34 (30%)

19 (17%)

55 (54%)

N = 101

< 0.001

0.22

0.36

3-year mortality**

117 (70%)

N = 167

59 (71%)

N = 83

58 (69%)

N = 84

0.77

Duration of ventilation

    

 Prior to trach (days), median [IQR]

 After trach (days), median [IQR]

Successful decannulation*** (n = 154)

19 [14–26]

12 [4–31]

126 (82%)

N = 137

17 [12–24]

6 [1–14]

69 (79%)

N = 78

21 [15–29]

23.5 [13–41]

57 (85%)

N = 59

< 0.001

< 0.001

0.36

Length of stay

    

 ICU (days), median, [IQR]

 Hospital (days), median, [IQR]

 New institutionalization****

41 [26–63]

85 [56–136]

49 (36%)

N = 137

31 [21–55]

97 [62–155]

37 (47%)

N = 78

51.5 [37–75]

76 [50–124]

12 (20%)

N = 59

< 0.001

0.002

0.002

  1. All numbers are n/group N (%) unless otherwise specified
  2. P values from Wilcoxon rank-sum test or Chi square test
  3. IQR = interquartile range
  4. *40 patients lost to follow up: 27 in secretion management category and 13 in prolonged ventilation category
  5. **80 patients lost to follow up: 50 in secretion management category and 30 in prolonged ventilation category
  6. ***6 patients lost to follow up: 3 in secretion management category and 3 in prolonged ventilation category
  7. ****24 patients lost to follow up: 12 in secretion management category and 12 in prolonged ventilation category